Stock Updates

Today’s Top Gainers in the Market Sanofi (NYSE:SNY) from Healthcare

Today’s top gainers include the company Sanofi (NYSE:SNY) which is in the industry Drug Manufacturers – Major, gaining 2.00% today. In the last week its performance is 1.01%, and -4.81% for the past quarter. Currently, Sanofi, SNY has a target price of 51.67, so today’s gain of 2.00% is a significant step towards its target price. The GAP today is therefore 2.24%.

Sanofi (NYSE:SNY), has a market cap of 98317.12, and is based in France. Insider ownership is at 16.40%, and institutional ownership is 10.30%.

At the current price of 39.18, it has a dividend yield of 4.24%, and its target price is 51.67. This is with a profit margin of *TBA, and total debt/equity of 0.32. Sanofi (NYSE:SNY) has a P/E of 22.02, as well as a forward P/E of 13.08.

With a current EPS of 1.78, and a forecasted EPS growth for next year at -1.80%,Sanofi (NYSE:SNY) has had a EPS growth for the past five years at -4.40%. For the next five years EPS growth is projected to be 6.40%.

Performance for the year is -17.64%. Since its IPO date on 7/1/2002, the total performance to date is -4.27%.

Volume today for Sanofi (NYSE:SNY), is 1288000, while its average volume is 2319.94. Whilst the total gain today was 2.00%, it did have a day high of -8.35%.

Volatility for this week has been at 0.75%, and 0.97% for the month. The 52-week low for Sanofi, SNY has been 8.50%, while the 52-week-high has reached -21.30%.

Looking at its return of investments, which is 6.50%, and its return on assets is *TBA. Sanofi (NYSE:SNY) has an operating margin of *TBA. With a sales growth of -4.40% quarter over quarter. Bearing in mind that Sanofi, SNY is in the sector Healthcare, its long-term debt/equity is 0.27, and has a current ratio of 1.5 and 1 for quick ratio.

So what is the value of Sanofi? Well its PEG is 3.44, and the P/S is 2.57, along with a P/B of 1.66. Meanwhile it has a p/cash of 14.15.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment